This grant will support research in two areas: molecular immunology and lipoprotein biochemistry. The common thread is our interest in the structure and dynamics of functional macromolecular complexes, particularly complexes formed between antibodies, antigens, complement and receptors, and also in complexes formed between proteins and lipids. The goal of the molecular immunology projects include elucidation of (i) the mechanisms by which antibody, through interaction with antigen, activates complement, (ii) the relationship between their structures and the dynamical properties of antibodies, and (iii) the ultrastructures of the complexes formed between antibodies and cellular receptors. The goals of the lipoprotein projects include elucidation of (i) the configuration of apoprotein B on the surface of the low density lipoproteins (LDL), (ii) the structural changes which ensue when very low density lipoproteins (VLDL) are catabolized by the lipoprotein lipases, and (iii) the changes in chylomicron structure which occur when temperature is lowered. The methodology to be utilized includes ultracentrifugation, diffusion, quasielastic light scattering, circular dichroism, stopped-flow fluorescence, time-resolved fluorescence depolarization, and electron microscopy. These projects are related to problems of health; thus, (i) the triggering of complement and cells by immune complexes and antigens is a critical feature of the immune defense, and (ii) high concentrations of chylomicron and VLDL 'remnants' remaining after lipolysis, and of LDL are closely associated with the development of tha atherosclerotic lesion, and associated heart attack, senility and stroke.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM013914-25
Application #
3268559
Study Section
Biophysics and Biophysical Chemistry B Study Section (BBCB)
Project Start
1976-09-01
Project End
1991-08-31
Budget Start
1989-09-01
Budget End
1990-08-31
Support Year
25
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Arts and Sciences
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Schumaker, V N; Phillips, M L; Chatterton, J E (1994) Apolipoprotein B and low-density lipoprotein structure: implications for biosynthesis of triglyceride-rich lipoproteins. Adv Protein Chem 45:205-48
Phillips, M L; Tao, M H; Morrison, S L et al. (1994) Human/mouse chimeric monoclonal antibodies with human IgG1, IgG2, IgG3 and IgG4 constant domains: electron microscopic and hydrodynamic characterization. Mol Immunol 31:1201-10
Phillips, M L; Lembertas, A V; Schumaker, V N et al. (1993) Physical properties of recombinant apolipoprotein(a) and its association with LDL to form an LP(a)-like complex. Biochemistry 32:3722-8
Lane, P D; Schumaker, V N; Tseng, Y et al. (1991) Isolation of human complement subcomponents C1r and C1s in their unactivated, proenzyme forms. J Immunol Methods 141:219-26
Schumaker, V N; Phillips, M L; Hanson, D C (1991) Dynamic aspects of antibody structure. Mol Immunol 28:1347-60
Poon, P H; Schumaker, V N (1991) Measurement of macromolecular interactions between complement subcomponents C1q, C1r, C1s, and immunoglobulin IgM by sedimentation analysis using the analytical ultracentrifuge. J Biol Chem 266:5723-7
Chatterton, J E; Phillips, M L; Curtiss, L K et al. (1991) Mapping apolipoprotein B on the low density lipoprotein surface by immunoelectron microscopy. J Biol Chem 266:5955-62
Phillips, M L; Oi, V T; Schumaker, V N (1990) Electron microscopic study of ring-shaped, bivalent hapten, bivalent antidansyl monoclonal antibody complexes with identical variable domains but IgG1, IgG2a and IgG2b constant domains. Mol Immunol 27:181-90
Phillips, M L; Schumaker, V N (1989) Conformation of apolipoprotein B after lipid extraction of low density lipoproteins attached to an electron microscope grid. J Lipid Res 30:415-22
Schumaker, V N; Tseng, Y; Poon, P H et al. (1989) Spontaneous activation of reconstituted and serum C1 and the role of C1-inhibitor. Behring Inst Mitt :102-10

Showing the most recent 10 out of 17 publications